135 related articles for article (PubMed ID: 38602310)
1. Revisiting the most often used item in the haematological tool box-The extent of haemodilution in bone marrow aspirates.
Hokland P
Br J Haematol; 2024 May; 204(5):1593-1594. PubMed ID: 38602310
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of massively diluted bone marrow cell samples aspirated from patients with myelodysplastic syndromes (MDS) or suspected of MDS: A retrospective analysis of nationwide samples in Japan.
Ogata K; Mochimaru Y; Kasai N; Sei K; Kawahara N; Ogata M; Yamamoto Y
Br J Haematol; 2024 May; 204(5):1856-1861. PubMed ID: 38590011
[TBL] [Abstract][Full Text] [Related]
3. Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses.
Loken MR; Chu SC; Fritschle W; Kalnoski M; Wells DA
Cytometry B Clin Cytom; 2009 Jan; 76(1):27-36. PubMed ID: 18548614
[TBL] [Abstract][Full Text] [Related]
4. Morphologic classification of the myelodysplastic syndromes (MDS): combined utilization of bone marrow aspirates and trephine biopsies.
Bartl R; Frisch B; Baumgart R
Leuk Res; 1992; 16(1):15-33. PubMed ID: 1732665
[TBL] [Abstract][Full Text] [Related]
5. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
6. Cytologic evaluation of Papanicolaou-stained bone marrow aspirates.
Berman JJ; McNeill RE
Diagn Cytopathol; 1989; 5(4):383-7. PubMed ID: 2482155
[TBL] [Abstract][Full Text] [Related]
7. [Survey on examinations for diagnosis of bone marrow failure in Japan: a report from the Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes].
Araseki K; Matsuda A; Tohyama K; Ishikawa T; Kawabata H; Miyazaki Y; Nakao S; Tomonaga M; Takaori-Kondo A; Kurokawa M; Omine M; Ozawa K
Rinsho Ketsueki; 2012 Jul; 53(7):691-7. PubMed ID: 22975771
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of histology and immunohistochemistry in myelodysplastic syndromes.
Horny HP; Sotlar K; Valent P
Leuk Res; 2007 Dec; 31(12):1609-16. PubMed ID: 17604834
[TBL] [Abstract][Full Text] [Related]
9. Screening bone marrow samples for abnormal lymphoid populations and myelodysplasia-related features with one 10-color 14-antibody screening tube.
Rajab A; Porwit A
Cytometry B Clin Cytom; 2015; 88(4):253-60. PubMed ID: 25664445
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of dysmyelopoiesis in cats: 34 cases (1996-2005).
Weiss DJ
J Am Vet Med Assoc; 2006 Mar; 228(6):893-7. PubMed ID: 16536701
[TBL] [Abstract][Full Text] [Related]
11. The role of magnetic resonance imaging in the diagnosis and monitoring of myelodysplastic syndromes or leukemia.
Takagi S; Tanaka O
Leuk Lymphoma; 1996 Nov; 23(5-6):443-50. PubMed ID: 9031074
[TBL] [Abstract][Full Text] [Related]
12. Role of bone marrow aspiration clots for evaluating cellularity: comparison of clots, biopsies, and smears.
Tanaka K; Hosoi H; Kodama R; Tabata S; Hiroi T; Kida Y; Mushino T; Murata S; Tamura S; Ikeda T; Sonoki T
Ann Hematol; 2021 Nov; 100(11):2843-2844. PubMed ID: 34259892
[No Abstract] [Full Text] [Related]
13. Prognostic significance of reproducible immunophenotypic markers of marrow dysplasia.
Della Porta MG; Picone C; Tenore A; Yokose N; Malcovati L; Cazzola M; Ogata K
Haematologica; 2014 Jan; 99(1):e8-10. PubMed ID: 24425693
[No Abstract] [Full Text] [Related]
14. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
[TBL] [Abstract][Full Text] [Related]
15. Collagenase digestion of bone marrow trephine biopsy specimens: an important adjunct to haematological diagnosis when marrow aspiration fails.
Maung ZT; Bown NP; Hamilton PJ
J Clin Pathol; 1993 Jun; 46(6):576-7. PubMed ID: 8331187
[TBL] [Abstract][Full Text] [Related]
16. "Bone marrow aspirate automated counts on hematology analyzers: formulating a scoring system based on hematology parameters, to discriminate reactive versus myelodysplastic syndrome-related bone marrows".
Tsagarakis NJ; Paterakis G; Papadhimitriou SI; Kritikou-Griva E; Goumakou E; Oudatzis G; Theodorakos I; Vasileiou P
Int J Lab Hematol; 2019 Aug; 41(4):542-549. PubMed ID: 31102331
[TBL] [Abstract][Full Text] [Related]
17. Utility of peripheral blood for cytogenetic and mutation analysis in myelodysplastic syndrome.
Mohamedali AM; Alkhatabi H; Kulasekararaj A; Shinde S; Mian S; Malik F; Smith AE; Gäken J; Mufti GJ
Blood; 2013 Jul; 122(4):567-70. PubMed ID: 23760614
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive bone marrow diagnosis on a single aspiration sample. Plastic sections and cell suspensions for enzyme and immunohisto- and cytochemistry.
van de Sandt MM; Herman CJ; Lindeman J
Pathol Annu; 1987; 22 Pt 1():67-82. PubMed ID: 3554122
[No Abstract] [Full Text] [Related]
19. A partial nucleated differential cell count of the bone marrow aspirate that is independent of peripheral blood dilution.
Lee SH; Ho SJ; Thomas DT; Giri P; Lee H; Sia H; To LB; Sullivan TR
Int J Lab Hematol; 2008 Dec; 30(6):473-9. PubMed ID: 18983299
[TBL] [Abstract][Full Text] [Related]
20. Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerations.
Alhan C; Westers TM; Cremers EM; Cali C; Ossenkoppele GJ; van de Loosdrecht AA
Cytometry B Clin Cytom; 2016 Jul; 90(4):358-67. PubMed ID: 26517178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
